article: Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society - Minerva Urology and Nephrology 2022 October;74(5):581-9 - Minerva Medica - Journals
No takes yet. Share an insight, caveat, or question.
Marra et al. (2022) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: